Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA LUPIN AUROBINDO PHARMA/
LUPIN
 
P/E (TTM) x 23.0 40.7 56.4% View Chart
P/BV x 2.4 6.0 39.7% View Chart
Dividend Yield % 0.3 0.2 111.4%  

Financials

 AUROBINDO PHARMA   LUPIN
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
LUPIN
Mar-23
AUROBINDO PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs715799 89.4%   
Low Rs397583 68.1%   
Sales per share (Unadj.) Rs424.2365.8 116.0%  
Earnings per share (Unadj.) Rs32.99.8 334.3%  
Cash flow per share (Unadj.) Rs54.129.2 185.4%  
Dividends per share (Unadj.) Rs3.004.00 75.0%  
Avg Dividend yield %0.50.6 93.2%  
Book value per share (Unadj.) Rs458.1270.7 169.2%  
Shares outstanding (eoy) m585.94454.98 128.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.9 69.4%   
Avg P/E ratio x16.970.2 24.1%  
P/CF ratio (eoy) x10.323.7 43.4%  
Price / Book Value ratio x1.22.6 47.5%  
Dividend payout %9.140.7 22.4%   
Avg Mkt Cap Rs m325,753314,381 103.6%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22330,872 114.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554166,417 149.4%  
Other income Rs m2,9061,509 192.6%   
Total revenues Rs m251,460167,926 149.7%   
Gross profit Rs m37,07017,206 215.5%  
Depreciation Rs m12,4468,807 141.3%   
Interest Rs m1,4052,743 51.2%   
Profit before tax Rs m26,1257,165 364.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8492,688 254.8%   
Profit after tax Rs m19,2774,477 430.6%  
Gross profit margin %14.910.3 144.3%  
Effective tax rate %26.237.5 69.9%   
Net profit margin %7.82.7 288.3%  
BALANCE SHEET DATA
Current assets Rs m214,599124,513 172.4%   
Current liabilities Rs m114,93892,654 124.1%   
Net working cap to sales %40.119.1 209.4%  
Current ratio x1.91.3 138.9%  
Inventory Days Days2126 78.6%  
Debtors Days Days6698 66.7%  
Net fixed assets Rs m176,668103,490 170.7%   
Share capital Rs m586910 64.4%   
"Free" reserves Rs m267,813122,246 219.1%   
Net worth Rs m268,399123,156 217.9%   
Long term debt Rs m6,190275 2,249.9%   
Total assets Rs m392,125228,003 172.0%  
Interest coverage x19.63.6 542.5%   
Debt to equity ratio x00 1,032.4%  
Sales to assets ratio x0.60.7 86.8%   
Return on assets %5.33.2 166.6%  
Return on equity %7.23.6 197.6%  
Return on capital %10.08.0 124.9%  
Exports to sales %33.70-   
Imports to sales %15.30-   
Exports (fob) Rs m83,703NA-   
Imports (cif) Rs m38,060NA-   
Fx inflow Rs m85,48348,057 177.9%   
Fx outflow Rs m41,44721,752 190.5%   
Net fx Rs m44,03626,306 167.4%   
CASH FLOW
From Operations Rs m23,86818,972 125.8%  
From Investments Rs m-39,778-12,868 309.1%  
From Financial Activity Rs m18,144-3,373 -538.0%  
Net Cashflow Rs m2,2982,732 84.1%  

Share Holding

Indian Promoters % 48.8 46.8 104.3%  
Foreign collaborators % 3.1 0.3 1,096.4%  
Indian inst/Mut Fund % 41.3 45.8 90.1%  
FIIs % 20.7 16.1 128.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 53.0 91.0%  
Shareholders   241,944 281,542 85.9%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Lupin Share Price Performance

Period Aurobindo Pharma Lupin S&P BSE HEALTHCARE
1-Day 1.82% 1.23% 1.18%
1-Month 5.96% 0.15% -0.75%
1-Year 113.07% 151.14% 61.82%
3-Year CAGR 7.78% 17.13% 18.16%
5-Year CAGR 7.18% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.